Dosidal · Switzerland
Xofluza, Granulat zur Herstellung einer Suspension zum Einnehmen
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:68068 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 68068 atc: J05AX25 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2021-11-19 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: J05AX25 authorisation_number: 68068 form: GRAS holder: Roche Pharma (Schweiz) AG holder_partner_nr: 1000726 it_number: 08.03.0. name: Xofluza, Granulat zur Herstellung einer Suspension zum Einnehmen state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53oKcn4FfgwPUk6f82Sa5QcaK8yaMLE18R3-5499qK4WYxrvROOfjeEKLB4WDrgi3hC3QfLyC6DklyRjNIFq4DYAVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |